| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |